---
title: 'Manager, Inventory and Operations Accounting at Vaxcyte'
canonical: 'https://feeny.ai/job/manager-inventory-and-operations-accounting-vaxcyte-san-carlos-r66rjpkp6y1a'
type: 'job'
last_seen: '2026-10-19'
---

# Manager, Inventory and Operations Accounting at Vaxcyte

- **Company:** Vaxcyte
- **Location:** San Carlos, CA
- **Posted:** 2026-10-14
- **Last confirmed live:** 2026-10-19
- **Apply:** https://boards.greenhouse.io/vaxcyte/jobs/5442376008?gh_jid=5442376008

## Job description

Join our Mission to Protect Humankind!

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.

WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:

*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.

*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.

*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.

*MODEL EXCELLENCE:  The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.

Summary:

The Manager, Inventory and Operations Accounting role will help manage Vaxcyte’s cost accounting functions, including standard costing, inventory valuation, and manufacturing variance analysis. This role also owns the full manufacturing accrual process for the Manufacturing Accounting Team — maintaining accrual trackers, preparing monthly accrual journal entries, reconciling manufacturing general ledger accounts, and preparing manufacturing flux analysis. The Manager, Inventory and Operations Accounting role partners closely with Supply Chain and FP&A to ensure accurate cost data, drive margin improvement initiatives, and maintain strong internal controls over inventory and cost of goods sold (COGS). The ideal candidate combines strong technical accounting skills with the ability to translate cost data into actionable business insights.

Essential Functions:

- Maintain and update standard costs for materials, labor, and overhead.
- Analyze and report on manufacturing variances (purchase price, usage, labor, and overhead) and partner with Supply Chain to explain and resolve root causes.
- Own the manufacturing accrual process end to end, including maintaining accrual trackers by key vendors.
- Prepare monthly accruals for manufacturing vendors, ensuring costs are recorded in the appropriate period.
- Prepare journal entries related to manufacturing accruals, inventory, COGS, and manufacturing variances.
- Manage inventory valuation, reserves, scrap and obsolescence, and reconciliation processes across all locations.
- Reconcile manufacturing and cost-related general ledger accounts and ensure timely, accurate month-end close.
- Prepare monthly and quarterly flux analysis for inventory, COGS and manufacturing accrual accounts.
- Maintain and execute internal controls over inventory, standard costing, COGS and manufacturing accruals in compliance with GAAP and Sarbanes-Oxley (SOX).
- Support quarterly external audits and SOX testing related to manufacturing, inventory, and cost accounting; manage requests, remediate deficiencies, and track corrective action plans.
- Investigate and resolve discrepancies identified in physical inventory counts and cycle counts.
- Support ERP and system enhancements related to inventory and cost accounting.
- Additional tasks and responsibilities as assigned.

Requirements:

- Bachelor’s degree in Accounting, Finance, or related field.
- 7+ years of progressive cost accounting experience in a biotech manufacturing environment, including contract manufacturing.  Other combinations of education and/or experience may be considered.
- Experience with product costing in SAP S/4 Hana required.
- Strong understanding of standard costing, variance analysis, and inventory accounting under GAAP.
- Advanced Excel skills.
- Strong analytical, problem-solving, and communication skills.
- CPA or CMA certification preferred.
- Experience working in a public company (SEC-reporting) environment preferred.
- Attention to detail and accuracy.
- Strong business acumen and ability to translate data into insights.
- Cross-functional collaboration and influence.
- Process improvement mindset.
- Ability to manage competing priorities and deadlines.

Reports to: Associate Accounting Director, Manufacturing

Location: San Carlos, CA

Work Arrangement (may be adjusted based on business needs, job responsibilities, or changes to company policy):

Hybrid (minimum of 3 days per week onsite)

Compensation: The compensation package will be competitive and includes comprehensive benefits and an equity component.

Salary Range: $145,000 – $169,000 (SF Bay Area). Salary ranges for non-California locations may vary.

## Equal Opportunity

We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.

Recruitment Fraud Notice

Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent Vaxcyte in recruitment activities. Vaxcyte has an established recruitment process for all positions prior to issuing an offer for employment and we will never extend unsolicited employment offers or ask candidates to provide financial or sensitive personal information as part of the application process. All legitimate communication from Vaxcyte will come from an official @vaxcyte.com email address. Qualified and interested candidates should apply to current openings at [vaxcyte.com/careers](https://vaxcyte.com/careers/).

## About Vaxcyte

## Company Overview
- **One-liner**: Vaxcyte is a clinical-stage biotechnology company re-engineering how vaccines are made to eliminate bacterial infections, using a cell-free protein synthesis platform to develop high-fidelity, broad-spectrum vaccines.
- **Entity Type**: Public (Ticker: PCVX)
- **Headquarters**: San Carlos, California, United States
- **Founded**: 2013 (as SutroVax; rebranded to Vaxcyte in 2020)
- **Founders**: Not publicly available (the company emerged from Sutro Biopharma’s spin-out)

## Core Business
- **Primary industry**: Biotechnology / Vaccines (Infectious Disease)
- **Target customers**: Global healthcare systems, public health organizations, and ultimately patients (B2B/Institutional); the company develops vaccines for both pediatric and adult populations.
- **Mission or purpose**: To protect humankind from the consequences of bacterial infections, eliminating diseases like invasive pneumococcal disease, Group A Strep, and Shigella.

## Products & Services
- **VAX-31 (31-valent PCV)**: A broad-spectrum pneumococcal conjugate vaccine candidate in Phase 3 for adults and Phase 2 for infants. Designed to cover over 95% of circulating IPD serotypes in U.S. adults 50+ and ~94% in infants. FDA Breakthrough Therapy designation granted.
- **VAX-24 (24-valent PCV)**: A pneumococcal conjugate vaccine candidate in Phase 2 for infants, designed to cover more serotypes than any infant PCV on the market today.
- **VAX-A1 (Group A Strep)**: A preclinical conjugate vaccine candidate for Group A Strep, a disease with no currently approved vaccine. Phase 1 first-in-human study (adults) underway in Australia.
- **VAX-GI (Shigella)**: A novel preclinical vaccine candidate targeting Shigella, a leading cause of diarrheal disease.
- **Platform Technology**: A proprietary cell-free protein synthesis platform that enables site-specific, carrier-sparing conjugation to produce precisely targeted vaccines with enhanced immunogenicity.

## Market Standing
- **Valuation/Market Cap**: ~$16.7 billion (as of early July 2026)
- **Key Metric**: Total funding raised (private) is not applicable; as a public company, key metrics include cash position (~$2.0 billion as of Q1 2026) and R&D investment. The company is pre-revenue.
- **Notable Investors/Partners**: Major institutional investors include Baker Bros. Advisors, Fidelity, and funds managed by BlackRock. Key partnership: exclusive license agreement with Sutro Biopharma for its cell-free protein synthesis platform.
- **Growth Signals**: 
  - Up to $1 billion commitment to expanding U.S. manufacturing with a new facility in North Carolina.
  - VAX-31 Phase 3 program (OPUS-1, OPUS-2, OPUS-3) topline data expected Q4 2026 – H1 2027.
  - Headcount growth: actively hiring across 100+ roles (Analytical, Commercial, Clinical, Conjugation, Quality, Regulatory).
  - Recognized as a Great Place to Work and Best Workplace in BioPharma (multiple years).

## Competitive Advantages
- **Broadest-spectrum PCV candidates**: VAX-31 is the broadest-spectrum pneumococcal conjugate vaccine in the clinic, targeting up to 31 serotypes.
- **Differentiated platform**: Cell-free protein synthesis allows for the creation of complex, high-fidelity vaccines that can overcome bacterial defense mechanisms (e.g., capsule-switching) that limit conventional cell-based vaccines.
- **Carrier-sparing technology**: Site-specific conjugation enables a higher valency (more serotypes) without compromising immunogenicity or tolerability.
- **Manufacturing scale**: Significant investment in U.S.-based production capacity provides a long-term supply chain advantage and aligns with "Investing in America" initiatives.

## Strategic Focus
- **Primary**: Advance VAX-31 and VAX-24 through late-stage clinical trials to secure regulatory approval and establish a new standard of care for pneumococcal disease.
- **Pipeline expansion**: Advance VAX-A1 (Group A Strep) and VAX-GI (Shigella) candidates through early clinical development.
- **Manufacturing**: Scale up internal manufacturing capabilities to support commercial launch and global supply.
- **Commercial readiness**: Building a commercial organization (e.g., hiring a VP of U.S. Market Access & Pricing, Senior Director of Product Launch) to prepare for potential VAX-31 launch.

## Why Work Here
- **Culture**: Described as a "kindness-first" mindset with a focus on audacious goals, collaboration, and mutual support. Recognized as a *Great Place to Work* and *Best Workplace in BioPharma* (Fortune).
- **Work Model**: Hybrid, Remote, and Onsite options available depending on role. San Carlos HQ offers a hybrid schedule.
- **Total Rewards**: 100% paid health, dental, and vision insurance; 401k matching; flexible PTO and holidays; paid parental and sick leave; equity awards (stock options & RSUs); Employee Stock Purchase Plan; lifestyle spending account; mental health and wellness resources.
- **Growth & Development**: Strong emphasis on learning culture, professional advancement through coaching, and career development programs.
- **Mission-driven**: Employees are directly contributing to creating vaccines that protect every child born and every adult at risk from bacterial infections globally.

## Sources
1. [vaxcyte.com](https://vaxcyte.com/)
2. [vaxcyte.com/careers](https://vaxcyte.com/careers/)
3. [vaxcyte.com/job-listings](https://vaxcyte.com/job-listings/)
4. [vaxcyte.com/culture](https://vaxcyte.com/culture/)
5. [vaxcyte.com/pipeline](https://vaxcyte.com/pipeline/)

## Other roles at Vaxcyte

- [Associate Director, Business Process Management & Operational Excellence](https://feeny.ai/job/associate-director-business-process-management-operational-excellence-vaxcyte-5p0t7q2tj3a5) — San Carlos, CA
- [Senior Accountant](https://feeny.ai/job/senior-accountant-vaxcyte-san-carlos-j4sqgfxb13nj) — San Carlos, CA
- [Scientist II (Contract), Analytical Development](https://feeny.ai/job/scientist-ii-contract-analytical-development-vaxcyte-san-carlos-zpsadm0x2qst) — San Carlos, CA
- [Systems Engineer](https://feeny.ai/job/systems-engineer-vaxcyte-san-carlos-zy2wf03ynbzs) — San Carlos, CA
- [Senior Associate Scientist, Research](https://feeny.ai/job/senior-associate-scientist-research-vaxcyte-san-carlos-908rwbsfgzv7) — San Carlos, CA
- [Associate Scientist II, Research](https://feeny.ai/job/associate-scientist-ii-research-vaxcyte-san-carlos-5ytv9687sh0g) — San Carlos, CA
- [IT Operations Engineer](https://feeny.ai/job/it-operations-engineer-vaxcyte-san-carlos-y9kstk4b8rz9) — San Carlos, CA
- [Manager, Facilities Engineering](https://feeny.ai/job/manager-facilities-engineering-vaxcyte-san-carlos-9z48ebpsa6x8) — San Carlos, CA
- [Associate Scientist I, Research](https://feeny.ai/job/associate-scientist-i-research-vaxcyte-san-carlos-k9qmt16gbeaw) — San Carlos, CA
- [Scientist I, Drug Product Analytics (Laboratory Automation)](https://feeny.ai/job/scientist-i-drug-product-analytics-laboratory-automation-vaxcyte-san-carlos-a3rh8631rv3k) — San Carlos, CA